Krónikus mieloid leukémia (CML): vizsgálatok itt: Egyesült Államok
100 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleTherapeutic RSK1 Targeting in Myeloid Malignancies
- Where
- St Louis
- Életkor
- 18 év and over
- People
- 30
- Run by
- Washington University School of Medicine
See details and how to joinNCT07379125 - 1. fázisTaking peopleTGRX-678 US Phase I for Chronic Myelogenous Leukemia Patients
- Where
- Houston, Seattle
- Életkor
- 18 év and over
- People
- 90
- Run by
- Shenzhen TargetRx Co., Ltd.
See details and how to joinNCT06088888 - 1. fázisTaking peopleOlutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
- Where
- Cleveland, Duarte
- Életkor
- 18 év and over
- People
- 15
- Run by
- City of Hope Medical Center
See details and how to joinNCT06543381 - 1/2. fázisTaking peopleA Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
- Where
- Augusta, Birmingham, Eugene, Fort Myers, Gilbert, Houston, Lone Tree, Nashville, New York, Ocala, Orange, Philadelphia, Portland, Salt Lake City, Seattle, St. Petersburg, West Palm Beach, Winston-Salem
- Életkor
- 18 év to 64 év
- People
- 330 worldwide
- Run by
- Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
See details and how to joinNCT06163430 · EU 2023-507677-18-00 - 2. fázisTaking peopleEffects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis
- Where
- Boston
- Életkor
- 18 év and over
- People
- 120
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06691217 - 2. fázisTaking peoplePhase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
- Where
- Houston
- Életkor
- 18 év and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07269470 - 1/2. fázisTaking peoplePhase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
- Where
- Houston
- Életkor
- 18 év and over
- People
- 66
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07128381 - 2. fázisTaking peopleTotal Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
- Where
- Duarte
- Életkor
- 18 év and over
- People
- 35
- Run by
- City of Hope Medical Center
See details and how to joinNCT07582172 - No phaseTaking peopleChart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
- Where
- Houston
- People
- 3000
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT00816114 - 1. fázisTaking peopleCPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- Where
- Houston
- Életkor
- 18 év and over
- People
- 38
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03896269 - 1/2. fázisTaking peopleAzacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- Where
- Houston
- Életkor
- 18 év and over
- People
- 97
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04140487 - 2/3. fázisTaking peopleA Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Where
- Atlanta, Boston, Buffalo, Charleston, Columbus, Dallas, Durham, Hackensack, Houston, Los Angeles, Miami, Milwaukee, Mineola, Nashville, New Haven, New York, Orange, Portland, Salem, Seattle, The Bronx
- Életkor
- 18 év and over
- People
- 316 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04256317 · EU 2024-515098-93-00 - Korai 1. fázisTaking peopleDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Where
- Baltimore
- Életkor
- 18 év and over
- People
- 8
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06398457 - 2. fázisTaking peoplePhase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib
- Where
- Houston
- Életkor
- 18 év and over
- People
- 50
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06817720 - 2. fázisTaking peopleAscorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
- Where
- Eau Claire, La Crosse, Mankato, Rochester
- Életkor
- 18 év and over
- People
- 80
- Run by
- Mayo Clinic
See details and how to joinNCT03418038 - 1. fázisTaking peopleA Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia
- Where
- Houston
- Életkor
- 18 év and over
- People
- 30
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06401603 - 1. fázisTaking peopleEdetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- Where
- Houston
- Életkor
- 1 év and over
- People
- 58
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03630991 - 1. fázisTaking peopleCLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
- Where
- Seattle
- Életkor
- 18 év and over
- People
- 120
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT04375631 - 2. fázisTaking peoplePonatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
- Where
- Houston
- Életkor
- 18 év and over
- People
- 50
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT01746836 - 2. fázisTaking people(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Atlanta, Birmingham, Boston, Charleston, Chicago, Cleveland, Duarte, Hialeah, Houston, Los Angeles, New York, Phoenix, Salt Lake City, Stanford
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 3. fázisTaking peopleStudy of Olverembatinib (HQP1351) in Patients With CML-CP
- Where
- Albuquerque, Amarillo, Anchorage, Augusta, Austin, Baltimore, Birmingham, Chattanooga, Chicago, Cleveland, Decatur, Detroit, Duarte, Edmonds, Goodyear, Greenville, Hackensack, Houston, Indianapolis, Irvine, Issaquah, La Jolla, Las Vegas, Lexington, Lincoln, Long Beach, Los Angeles, Louisville, Mayfield Heights, Morristown, Morrisville, Nashville, New Brunswick, Newnan, Philadelphia, Pittsburgh, Portland, Reno, Rochester, Sacramento, Seattle, Shirley, St Louis, Stony Brook, Upland, Virginia Beach, Wichita
- Életkor
- 18 év and over
- People
- 333 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06423911 · EU 2024-511495-32-00 - 2. fázisTaking peopleEnasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
- Where
- Houston
- Életkor
- 18 év and over
- People
- 50
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03683433 - 2. fázisNot yet taking people in Egyesült ÁllamokDepletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome
- Where
- Seattle
- People
- 52
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07819396 - 2. fázisTaking peopleA Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
- Where
- Houston, Miami
- Életkor
- 18 év and over
- People
- 15
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06566742 - 2. fázisTaking peopleAzacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- Where
- Baltimore, Cleveland, Houston
- Életkor
- 12 év and over
- People
- 63
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03383575